Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorBülbül, Y.
dc.contributor.authorÖzlu, T.
dc.contributor.authorArınç, Sibel
dc.contributor.authorÖzyürek, Berna A.
dc.contributor.authorGünbatar, Hülya
dc.contributor.authorŞentürk, Ayşegül
dc.contributor.authorTalay, F.
dc.contributor.authorMutlu, Levent Cem
dc.date.accessioned2022-05-11T14:39:47Z
dc.date.available2022-05-11T14:39:47Z
dc.date.issued2017
dc.identifier.issn1011-7571
dc.identifier.issn1423-0151
dc.identifier.urihttps://doi.org/10.1159/000452801
dc.identifier.urihttps://hdl.handle.net/20.500.11776/8727
dc.description.abstractObjective: To investigate the symptoms of lung cancer in Turkey and to evaluate approaches to alleviate these symptoms. Subjects and Methods: This study included 1,245 lung cancer patients from 26 centers in Turkey. Demographic characteristics as well as information regarding the disease and treatments were obtained from medical records and patient interviews. Symptoms were evaluated using the Edmonton Symptom Assessment Scale (ESAS) and were graded on a scale between 0 and 10 points. Data were compared using the. 2, Student t, and Mann-Whitney U tests. Potential predictors of symptoms were analyzed using logistic regression analysis. Results: The most common symptom was tiredness (n = 1,002; 82.1%), followed by dyspnea (n = 845; 69.3%), appetite loss (n = 801; 65.7%), pain (n = 798; 65.4%), drowsiness (n = 742; 60.8%), anxiety (n = 704; 57.7%), depression (n = 623; 51.1%), and nausea (n = 557; 45.5%). Of the 1,245 patients, 590 (48.4%) had difficulty in initiating or maintaining sleep. The symptoms were more severe in stages III and IV. Logistic regression analysis indicated a clear association between demographic characteristics and symptom distress, as well as between symptom distress (except nausea) and well-being. Overall, 804 (65.4%) patients used analgesics, 630 (51.5%) received treatment for dyspnea, 242 (19.8%) used enteral/parenteral nutrition, 132 (10.8%) used appetite stimulants, and 129 (10.6%) used anxiolytics/antidepressants. Of the 799 patients who received analgesics, 173 (21.7%) reported that their symptoms were under control, and also those on other various treatment modalities (dyspnea: 78/627 [12.4%], appetite stimulant: 25/132 [18.9%], and anxiolytics/antidepressants: 25/129 [19.4%]) reported that their symptoms were controlled. Conclusion: In this study, the symptoms progressed and became more severe in the advanced stages of lung cancer, and palliative treatment was insufficient in most of the patients in Turkey. (C) 2016 S. Karger AG, Baselen_US
dc.language.isoengen_US
dc.publisherKargeren_US
dc.identifier.doi10.1159/000452801
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectLung canceren_US
dc.subjectPalliationen_US
dc.subjectPalliative treatmenten_US
dc.subjectSymptomsen_US
dc.subjectTreatmenten_US
dc.subjectQuality-Of-Lifeen_US
dc.subjectSleep Disturbancesen_US
dc.subjectSymptom Experienceen_US
dc.subjectSupportive Careen_US
dc.subjectPainen_US
dc.subjectChemotherapyen_US
dc.subjectPrevalenceen_US
dc.subjectImpacten_US
dc.titleAssessment of Palliative Care in Lung Cancer in Turkeyen_US
dc.typearticleen_US
dc.relation.ispartofMedical Principles and Practiceen_US
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Göğüs Hastalıkları Ana Bilim Dalıen_US
dc.authorid0000-0003-1645-7761
dc.authorid0000-0001-8125-9062
dc.authorid0000-0002-6048-1462
dc.authorid0000-0002-3535-5704
dc.authorid0000-0003-4881-3097
dc.authorid0000-0003-1645-7761
dc.authorid0000-0002-7163-4882
dc.identifier.volume26en_US
dc.identifier.issue1en_US
dc.identifier.startpage50en_US
dc.identifier.endpage56en_US
dc.institutionauthorMutlu, Levent Cem
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.authorscopusid6603476386
dc.authorscopusid6602072789
dc.authorscopusid6504134239
dc.authorscopusid46961370100
dc.authorscopusid54406819200
dc.authorscopusid55004284300
dc.authorscopusid56702561200
dc.authorwosidErol, Serhat/H-2486-2016
dc.authorwosidozcelik, melike/AAS-7557-2020
dc.authorwosidBULBUL, YILMAZ/AAN-1357-2021
dc.authorwosidKilic, Talat/ABI-4457-2020
dc.authorwosidKerget, Bugra/AAC-2299-2020
dc.authorwosidMutlu, Levent Cem/AAZ-5186-2020
dc.authorwosidOzlu, Tevfik/AAN-2845-2021
dc.identifier.wosWOS:000391457100008en_US
dc.identifier.scopus2-s2.0-84992688577en_US
dc.identifier.pmid27780164en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster